Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
According to a press release from Arla Foods Ingredients, the company has reached an agreement to acquire Volac International's Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited. The transaction is expected to be completed later this year, subject to regulatory approval.
Arla says that it envisions Volac’s facility in Felinfach, Wales as a global production hub and the cornerstone of product offerings in the performance, health, and food sectors. “This brings together two complementary offerings in a growing and increasingly international space for whey products,” said Luis Cubel, vice president and managing director of Arla Foods, in a press release. “Volac is a pioneer in the use of whey protein for performance nutrition and has a wealth of expertise as well as an incredibly talented team. It shares our commitment to helping companies worldwide harness the full potential of whey, and we’re hugely excited about the opportunities that lie ahead.”
“Whey processing started at the Felinfach site more than three decades ago, and we couldn’t be prouder of everything that’s been achieved by everyone involved in the business since then,” said James Neville, joint owner of Volac on behalf of the Neville family. “When considering the future of Volac Whey Nutrition and the opportunities that lie ahead for that business, it was crucial for us to choose a partner with the right values and expertise. Arla Foods Ingredients has the ambition and the knowledge to take the business to the next level.”
Volac was advised by Houlihan Lokey (Financial), Ashurst (Legal), PWC (Financial due diligence), OCC (Commercial due diligence). Arla Foods Ingredients was advised by Norton Rose Fulbright (Legal) and EY (Financial and tax)
Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States
September 11th 2024The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.